Norepinephrine Bitartrate In Sodium Chloride Injection, Solution
NDC Package 44567-643-10
Package Information
Norepinephrine Bitartrate In Sodium Chloride (norepinephrine bitartrate) injection is norepinephrine Bitartrate in Sodium Chloride Injection is indicated to raise blood pressure in adult patients with severe, acute hypotension. This formulation utilizes a injection, solution delivery system. Marketed by Wg Critical Care, Llc, this product is identified by NDC 44567-643 and is authorized under FDA application NDA215700.
Identification & Billing
- RxCUI: 2475337 - norepinephrine bitartrate 4 MG in 250 ML Injection
- RxCUI: 2475337 - 250 ML norepinephrine 0.016 MG/ML Injection
- RxCUI: 2475337 - norepinephrine (as bitartrate) 4 MG per 250 ML Injection
- RxCUI: 2475340 - norepinephrine bitartrate 8 MG in 250 ML Injection
- RxCUI: 2475340 - 250 ML norepinephrine 0.032 MG/ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 44567 - Wg Critical Care, Llc
- 44567-643 - Norepinephrine Bitartrate In Sodium Chloride
- 44567-643-10 - 10 BAG in 1 CARTON / 250 mL in 1 BAG (44567-643-01)
- 44567-643 - Norepinephrine Bitartrate In Sodium Chloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44567-643-10 identifies a specific commercial package of 10 bag in 1 carton / 250 ml in 1 bag (44567-643-01) of Norepinephrine Bitartrate In Sodium Chloride, a human prescription drug labeled by Wg Critical Care, Llc. This injection, solution is formulated for intravenous use and contains norepinephrine bitartrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wg Critical Care, Llc on September 15, 2022. The current certification is valid through December 31, 2027.
How is this Wg Critical Care, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44567064310. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.